Procurement of Specialized Oncology Pharmaceuticals and Medical Supplies

Work Description - NA

The Department of Military Affairs, under the Ministry of Defence, and specifically the Indian Army, is issuing this tender for the procurement of a comprehensive range of critical pharmaceutical supplies. This bid, identified by Bid Number GEM/2026/B/7571595, pertains to a substantial quantity of 63,648 units of specialized medications and medical consumables. The listed items encompass a diverse array of oncology drugs, including but not limited to Bevacizumab, Vinblastine Sulphate, Tegafur formulations (with Gimeracil and Oteracil), Ramucirumab, Temozolamide, Vinorelbine, Megestrol Acetate, Leucovorin Calcium, Trabectedin, Cabazitaxel, Pertuzumab and Trastuzumab combination therapy, Fosaprepitant, Aprepitant, Oxaliplatin, Gefitinib, and Cabozantinib. Additionally, the tender includes prefilled 0.9 percent Sodium Chloride flush injections, chemoport needles (20G or 22G), and antiemetic combinations such as Netupitant/Palonosetron and Palonosetron oral injections. The bidding period for this crucial requirement will commence on 11th August 2026 at 10:00 AM and conclude on 12th August 2026 at 10:00 AM. This procurement, dated 08th June 2026, is essential for maintaining the health and operational readiness of personnel, and interested and qualified suppliers are invited to submit their proposals.